5.75Open5.75Pre Close0 Volume101 Open Interest35.00Strike Price0.00Turnover80.49%IV2.73%PremiumSep 20, 2024Expiry Date4.93Intrinsic Value100Multiplier4DDays to Expiry0.82Extrinsic Value100Contract SizeAmericanOptions Type-0.9685Delta0.0328Gamma6.07Leverage Ratio-0.0156Theta-0.0020Rho-5.88Eff Leverage0.0021Vega
Pfizer Stock Discussion
The chart shows a rising window, gap up. The stock has turned bullish. Next resistance is 30.05. Once break the resistance, next hit point will be 30.50.
Baird's optimism is driven by promising developments in Instil’s PD-L1xVEGF bispecific antibody, especially following positive data from peers like Akeso and Summit. Analysts believe this drug class has strong potentia...
going
down
again
As of September 10, Pfizer's stock price has risen by about 7% since June 2024, which could be just the beginning of its growth momentum. The pharmaceutical giant's non-COVID product line has performed strongly, and Wall Street analysts are predicting that its earnings per share will bottom out in fiscal year 2024, indicating that Pfizer's recovery is just starting.
In the second quart...
This thing is going to move next week. if there is a pop, better get out while you still can. I will say told you so when it's at 630. Ha.....What that's not going to happen? I guess the meaning of overvalued doesn't exist in this generation. even at half price, this is still overvalued. The only way this thing is worth 1T is if LLY discovered a longevity pill.
$Pfizer (PFE.US)$
$SPDR S&P 500 ETF (SPY.US)$
The share price finally stays above 29 today. Hope to see it going to 30 and above next week✌️
$Intel (INTC.US)$ shares rose 9.49% Friday to close at $22.04. Its options trading volume was 1.18 million. Call contracts account for 71.8% of the total trading volume. The $22 calls expiring Aug. 30 were traded most actively.
Intel experienced a notable surge, climbing 9.9% to reach an intraday high of $22.12, following a report by Bloomberg News. The report, which cited "un...
No comment yet